Table 5.
Cumulative Odds Ratios for Comparative Studies (DES versus BMS)
| Time | Contributing studies | DES (n) |
BMS (n) |
OR (95% CI) |
P value | |
|---|---|---|---|---|---|---|
| Mortality | 6–12months | Erglis 2007(12) | 53 | 50 |
0.94 (0.06–15.48) |
p=0.97 |
| 2 years | Han 2009 (78) Palmerini 2007 (40) Schrale 2008 (82) |
1344 | 496 |
0.42 (0.28–0.62) |
p<0.01 | |
| 3 years | Kim 2009 (80) Tamburino 2009 (83) Tamburino 2009 (84) |
1809 | 736 |
0.70 (0.53–0.92) |
p=0.01 | |
| MI | 6–12 months | Erglis 2007(12) | 53 | 50 |
0.64 (0.19–2.17) |
p= 0.47 |
| 2 years | Han 2009 (78) | 178 | 109 |
0.16 (0.01–3.53) |
p=0.13 | |
| 3 years | Tamburino 2009 (83) | 611 | 238 |
0.49 (0.26–0.92) |
p=0.03 | |
| TVR/TLR | 6–12 months | Erglis 2007(12) | 53 | 50 |
0.10 (0.01–0.84) |
p=0.01 |
| 2 years | No studies | -- | -- | -- | -- | |
| 3 years | Kim 2009 (80) Tamburino 2009 (83) Tamburino 2009 (84) |
1809 | 736 |
0.46 (0.30–0.69) |
p<0.01 | |
| MACE | 6–12 months | Chieffo 2005 (76) Erglis 2007(12) |
138 | 114 |
0.34 (0.15–0.78) |
P=0.01 |
| 2 years | Gao 2008 (77) Han 2009 (78) |
398 | 333 |
0.31 (0.15–0.66) |
P<0.01 | |
| 3 years | Kim 2009 (80) Tamburino 2009 (84) |
1198 | 498 |
0.78 (0.57–1.07) |
P=0.12 |
*
n refers to the number of patients within the studies who contributed to the estimate of interest. OR are reported with 95% confidence intervals.